These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32812487)

  • 1. Inflammatory activity following motor progression due to critical CNS demyelinating lesions.
    Nayak S; Sechi E; Flanagan EP; Messina S; Kassa R; Kantarci O; Weinshenker BG; Keegan BM
    Mult Scler; 2021 Jun; 27(7):1037-1045. PubMed ID: 32812487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment.
    Keegan BM; Messina SA; Hanson D; Holmes D; Camp J; Sechi E; Nayak S; Barakat B; Ahmad R; Mandrekar J; Harmsen WS; Kantarci O; Weinshenker BG; Flanagan EP
    AJNR Am J Neuroradiol; 2024 Jul; 45(7):943-950. PubMed ID: 38754997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions.
    Kassa RM; Sechi E; Flanagan EP; Kaufmann TJ; Kantarci OH; Weinshenker BG; Mandrekar J; Schmalstieg WF; Paz Soldan MM; Keegan BM
    Mult Scler; 2021 May; 27(6):895-902. PubMed ID: 32667237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease.
    Keegan BM; Kaufmann TJ; Weinshenker BG; Kantarci OH; Schmalstieg WF; Paz Soldan MM; Flanagan EP
    Mult Scler; 2018 Oct; 24(11):1445-1452. PubMed ID: 30047830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
    Keegan BM; Kaufmann TJ; Weinshenker BG; Kantarci OH; Schmalstieg WF; Paz Soldan MM; Flanagan EP
    Neurology; 2016 Oct; 87(16):1713-1719. PubMed ID: 27638926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral motor progression in MS: Association with a critical corticospinal tract lesion.
    Sechi E; Keegan BM; Kaufmann TJ; Kantarci OH; Weinshenker BG; Flanagan EP
    Neurology; 2019 Aug; 93(7):e628-e634. PubMed ID: 31289142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
    Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study.
    Sechi E; Messina S; Keegan BM; Buciuc M; Pittock SJ; Kantarci OH; Weinshenker BG; Flanagan EP
    Mult Scler; 2021 Apr; 27(5):667-673. PubMed ID: 32552535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion.
    Schmalstieg WF; Keegan BM; Weinshenker BG
    Neurology; 2012 Feb; 78(8):540-4. PubMed ID: 22323754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive motor impairment from "critical" demyelinating lesions of the cervicomedullary junction.
    Jackson-Tarlton CS; Flanagan EP; Messina SA; Barakat B; Ahmad R; Kantarci OH; Weinshenker BG; Keegan BM
    Mult Scler; 2023 Jan; 29(1):74-80. PubMed ID: 36000479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
    Sorensen PS; Sellebjerg F; Hartung HP; Montalban X; Comi G; Tintoré M
    Brain; 2020 Sep; 143(9):2637-2652. PubMed ID: 32710096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
    Elliott C; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Wei W; Belachew S; Arnold DL
    Mult Scler; 2019 Dec; 25(14):1915-1925. PubMed ID: 30566027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
    Sormani MP; Stubinski B; Cornelisse P; Rocak S; Li D; De Stefano N
    Mult Scler; 2011 May; 17(5):541-9. PubMed ID: 21148262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions.
    Barakat B; Messina S; Nayak S; Kassa R; Sechi E; Flanagan EP; Kantarci O; Weinshenker BG; Keegan BM
    Mult Scler J Exp Transl Clin; 2022; 8(1):20552173211052159. PubMed ID: 35047187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study).
    Pérez-Miralles F; Prefasi D; García-Merino A; Ara JR; Izquierdo G; Meca-Lallana V; Gascón-Giménez F; Martínez-Ginés ML; Ramió-Torrentà L; Costa-Frossard L; Fernández Ó; Moreno-García S; Medrano N; Maurino J; Casanova B
    Mult Scler Relat Disord; 2021 May; 50():102860. PubMed ID: 33647591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.